NCT00141362已完成3 期
An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Chronic Neuropathic Pain.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 325
- 主要终点
- Safety and efficacy
研究概览
简要总结
Evaluate long-term safety and efficacy of pregabalin in patients with chronic neuropathic pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must have met the inclusion criteria for the preceding double-blind BID study in diabetic neuropathy or postherpetic neuralgia.
- •Must have received study medication under double-blind conditions.
排除标准
- •Patients cannot participate if they experienced a serious adverse event during the previous double-blind BID study which was determined to be related to the study medication.
结局指标
主要结局
Safety and efficacy
次要结局
未报告次要终点
研究者
相似试验
已完成
3 期
To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.Neuropathic PainNCT00141375Pfizer132
已完成
3 期
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.NeuralgiaNCT00150436Pfizer276
已完成
3 期
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral NeuropathyDiabetic Neuropathy, PainfulNCT00553280Pfizer's Upjohn has merged with Mylan to form Viatris Inc.123
终止
3 期
Pregabalin Trial In HIV Neuropathic PainHIV-1 InfectionNeuropathic PainNCT01145417Pfizer's Upjohn has merged with Mylan to form Viatris Inc.217
已完成
3 期
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With FibromyalgiaFibromyalgiaNCT00830128Pfizer's Upjohn has merged with Mylan to form Viatris Inc.106